Evidence map›Paper›PMID 21892160›Full record

ArticleNature genetics2011

Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans.

Loïc de Pontual, Evelyn Yao, Patrick Callier, Laurence Faivre, Valérie Drouin, Sandra Cariou, Arie Van Haeringen, David Geneviève, Alice Goldenberg, Myriam Oufadem and 8 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 1 synthesis or guideline pooled it, 306 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. AGO2 silences mobile transposons in the nucleus of quiescent cells.Nature structural & molecular biology · 2023
    Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Loïc de PontualUnité INSERM U-781, Université Paris Descartes, Paris, France.
Evelyn Yao
Patrick Callier
Laurence Faivre
Valérie Drouin
Sandra Cariou
Arie Van Haeringen
David Geneviève
Alice Goldenberg
Myriam Oufadem
Sylvie Manouvrier
Arnold Munnich
Joana Alves Vidigal
Michel Vekemans
Stanislas Lyonnet
Alexandra Henrion-Caude
Andrea Ventura
Jeanne Amiel
Délégation Paris 5 · FRMemorial Sloan Kettering Cancer Center · USHôpital Charles-Nicolle · FRHôpital d'Enfants · FRUniversité Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Arnaud de Villeneuve · FRHôpital Jeanne de Flandre · FRHôpital Necker-Enfants Malades · FRInserm · FRLeiden University Medical Center · NL

Funding

Investigating the functions of the miR-17~92 family of oncogenic microRNA clustersR01CA149707 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VENTURA, ANDREA · 2010 to 2021
$3.8M
NCI NIH HHS R01 CA149707NCI NIH HHS R01CA149707
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are key regulators of gene expression in animals and plants. Studies in a variety of model organisms show that miRNAs modulate developmental processes. To our knowledge, the only hereditary condition known to be caused by a miRNA is a form of adult-onset non-syndromic deafness, and no miRNA mutation has yet been found to be responsible for any developmental defect in humans. Here we report the identification of germline hemizygous deletions of MIR17HG, encoding the miR-17∼92 polycistronic miRNA cluster, in individuals with microcephaly, short stature and digital abnormalities. We demonstrate that haploinsufficiency of miR-17∼92 is responsible for these developmental abnormalities by showing that mice harboring targeted deletion of the miR-17∼92 cluster phenocopy several key features of the affected humans. These findings identify a regulatory function for miR-17∼92 in growth and skeletal development and represent the first example of an miRNA gene responsible for a syndromic developmental defect in humans.

Indexed as

Gene DeletionGerm-Line MutationMultigene FamilyAnimalsChromosomes, Human, Pair 13Databases, GeneticDuodenal ObstructionEmbryo, MammalianEsophageal AtresiaEyelidsFemaleHaploinsufficiencyHumansIntellectual DisabilityLimb Deformities, CongenitalMaleMicroRNAs

Identifiers

PMID21892160
PMCPMC3184212
OpenAlexW1998770186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.